Repligen Overview
Repligen Target Price
Analysts' 12-month price predictions for RGEN.
Get informed when a big investor buys or sells
+ FollowShare Price
$142.4
Average Target Price
$150.40
5.6% upside
5.6% upside5 analysts in the last 4 months
High: $160 | Low: $142
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-14 | RBC CapitalDan Leonard | $160 | 12.4% upside |  |
| 2026-05-05 | JefferiesMatthew Stanton | $142 |  0.3% downside | |
| 2026-04-20 | Canaccord Genuity | $145 | 1.8% upside | |
| 2026-04-17 | Redburn Partners | $160 | 12.4% upside | |
| 2026-04-14 | BarclaysLuke Sergott | $145 | 1.8% upside | |
| 2026-01-16 | UBSDan Leonard | $200 | 40.4% upside | |
| 2025-12-15 | Barclays | $200 | 40.4% upside | |
| 2025-12-15 | Wells Fargo | $190 | 33.4% upside | |
| 2025-10-29 | Canaccord Genuity | $165 | 15.9% upside | |
| 2025-10-29 | Barclays | $175 | 22.9% upside | |
| 2025-10-28 | JefferiesMatthew Stanton | $160 | 12.4% upside | |
| 2025-10-02 | BarclaysLuke Sergott | $160 | 12.4% upside | |
| 2025-10-01 | HSBC | $150 | 5.3% upside | |
| 2025-09-02 | RBC Capital | $205 | 44% upside | |
| 2024-11-12 | KeyBancPaul Knight | $220 | 54.5% upside | |
| 2024-07-31 | J.P. MorganRachel Vatnsdal | $200 | 40.4% upside | |
| 2024-07-31 | UBSElizabeth Garcia | $185 | 29.9% upside | |
| 2024-06-26 | Deutsche BankJustin Bowers | $155 | 8.8% upside | |
| 2024-06-21 | Stifel NicolausDaniel Arias | $207 | 45.4% upside | |
| 2023-01-06 | Leerink Partners | $200 | 40.4% upside | |
| 2022-12-14 | Deutsche Bank | $180 | 26.4% upside | |
| 2022-12-07 | RBC Capital | $190 | 33.4% upside | |
| 2022-04-28 | Leerink Partners | $220 | 54.5% upside | |